The relation between bisphosphonate use and non-union of fractures of the humerus in older adults
Authors:
- 9 October 2008
- journal article
- research article
- Published by Springer Nature in Osteoporosis International
- Vol. 20 (6) , 895-901
Abstract
Summary While nitrogen-containing bisphosphonates have been shown to reduce fracture risk in postmenopausal women and men, their safety in the period after a fracture is unclear. In fully adjusted multivariable regression models, bisphosphonate use in the post-fracture period was associated with an increased probability of non-union [odds ratio (OR) 2.37, 95% confidence interval (CI) 1.13–4.96]. Clinicians might consider waiting for several months before introduction of a bisphosphonate after a fracture. Introduction While nitrogen-containing bisphosphonates have been shown to reduce fracture risk in postmenopausal women and men, their safety in the period after a fracture is unclear. We examined the risk of non-union associated with post-fracture bisphosphonate use among a group of older adults who had experienced a humerus fracture. Methods We conducted a nested case–control study among subjects who had experienced a humerus fracture. From this cohort, cases of non-union were defined as those with an orthopedic procedure related to non-union 91–365 days after the initial humerus fracture. Bisphosphonate exposure was assessed during the 365 days prior to the non-union among cases or the matched date for controls. Multivariable logistic regression models were examined to calculate the OR and 95% CI for the association of post-fracture bisphosphonate use with non-union. Results From the cohort of 19,731 patients with humerus fractures, 81 (0.4%) experienced a non-union. Among the 81 cases, 13 (16.0%) were exposed to bisphosphonates post-fracture, while 69 of the 810 controls (8.5%) were exposed in the post-fracture interval. In fully adjusted multivariable regression models, bisphosphonate use in the post-fracture period was associated with an increased odds of non-union (OR 2.37, 95% CI 1.13–4.96). Albeit limited by small sample sizes, the increased risk associated with bisphosphonate use persisted in the subgroup of patients without a history of osteoporosis or prior fractures (OR 1.91, 95% CI 0.75–4.83). Conclusions In this study of older adults, non-union after a humerus fracture was rare. Bisphosphonate use after the fracture was associated with an approximate doubling of the risk of non-union.Keywords
This publication has 21 references indexed in Scilit:
- Zoledronic Acid and Clinical Fractures and Mortality after Hip FractureNew England Journal of Medicine, 2007
- Optimal Timing of a Single Dose of Zoledronic Acid to Increase Strength in Rat Fracture RepairJournal of Bone and Mineral Research, 2007
- The anabolic and catabolic responses in bone repairThe Journal of Bone and Joint Surgery. British volume, 2007
- Nonsteroidal antiinflammatory drugs and nonunion of humeral shaft fracturesArthritis & Rheumatism, 2005
- A review of uses of health care utilization databases for epidemiologic research on therapeuticsJournal of Clinical Epidemiology, 2005
- Raloxifene, Estrogen, and Alendronate Affect the Processes of Fracture Repair Differently in Ovariectomized RatsJournal of Bone and Mineral Research, 2002
- Concentration of Bisphosphonate (Incadronate) in Callus Area and Its Effects on Fracture Healing in RatsJournal of Bone and Mineral Research, 2000
- The effects of risedronate on canine cancellous bone remodeling: Three-dimensional kinetic reconstruction of the remodeling siteJournal of Bone and Mineral Research, 1995
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992
- Nonunion of the Proximal HumerusJournal of Orthopaedic Trauma, 1990